This report analyses the factors affecting access to treatment regimens for drug-resistant tuberculosis (DR-TB), including new and repurposed drugs. Detailed pricing profiles of key DR-TB drugs are also provided.
Favorite
International Agencies
Policy Makers
2016
This fact sheet provides information on latent tuberculosis infection (LTBI) for patients.
Favorite
Persons With LTBI
2016
These guidelines aim to reduce morbidity and mortality related to TB and HIV-associated TB among people who inject drugs (PWID) through the integrated delivery of a comprehensive and holistic package of care. The guidelines provide an update of the 2008 Policy guidelines for collaborative TB and HIV services for injecting and other drug users: an integrated approach.
Favorite
2016
This quick reference tool provides suggestions for replacing stigmatizing language with non-hurtful words and phrases.
Favorite
2016
This guide provides an epidemiological profile of childhood TB, outlines the barriers to diagnosis and treatment, discusses strategies for improved access,and highlights opportunities for the involvement of children and their caregivers in all stages of program development and service delivery.
Favorite
Policy Makers
2016
This report details the steps that governments of countries with high burdens of TB-HIV and their partners have taken to turn a coordinated response to TB-HIV into reality at the country level, as well as the remaining gaps.
Favorite
International Agencies
Policy Makers
2016
The purpose of this document is to provide guidance for clinicians, nurses, and hospital infection preventionists on the use of the Xpert MTB/RIF assay when making decisions to discontinue airborne infection isolation for persons with suspected, infectious pulmonary TB.
Favorite
Infection Control and Occupational Health Workers
2016
This video provides information on how to administer directly observe therapy (DOT).
Favorite
Outreach Workers
2016
This quick reference guide provides information on how to correctly administer and read a tuberculin skin test (TST).
Favorite
2016
This website contains resources, materials, and links to latent TB infection and U.S. Preventive Services Task Force (USPSTF) materials.
Favorite
2016
This slide set was developed as an accompaniment to Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection, a joint statement by CDC and the American Thoracic Society, and subsequent updates. The slide set provides an overview of the current recommendations for the testing and treatment of latent tuberculosis.
Favorite
2016
This report provides surveillance data, concise summaries of core program activities, and highlights for 2015.
Favorite
Health Educators/Communicators
2016
This guide aims to improve case detection, management, and outcomes of children with TB.
Favorite
2016
The WHO treatment guidelines for drug-resistant TB contains policy recommendations on priority areas in the treatment of drug-resistant TB.
Favorite
2016
This resource provides access to a variety of tools that enable health professionals to quickly and easily find information about TB in an emergency department setting.
Favorite
2016
WHO has published a global TB report every year since 1997. The main aim of the report is to provide a comprehensive and up-to-date assessment of the TB epidemic, and of progress in prevention, diagnosis and treatment of the disease at global, regional and country levels. This report is updated annually.
Favorite
International Agencies
Managers and Supervisors
Policy Makers
2016
This brochure describes Mycobacterium bovis (bovine tuberculosis) in humans and in cattle.
Favorite
2016
This document describes the steps necessary to implement the shorter regimen and the new drugs for drug-resistant TB treatment, including diagnosis and bacterial confirmation of drug resistance, treatment regimen design, monitoring of treatment efficacy and safety, and programmatic evaluation.
Favorite
International Agencies
2016
This fact sheet provides an overview of treating TB disease in persons infected with HIV/AIDS.
Favorite
2016
This report presents summary data for U.S. TB cases reported to the Division of TB Elimination, CDC, during 2015.
Favorite
Policy Makers
2016